QuickView for nonhomologous end joining complex (biogroup)

1. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
2. Suppression of breast tumor growth and metastasis by an engineered transcription factor
3. L1000 CMAP - Non-small cell lung cancer A549.311 cells with CRISPR targeted gene knockouts
4. L1000 CMAP - T-cell ALL JURKAT cells treated with small molecule perturbagens
5. L1000 CMAP - Embryonic stem HUES3 cells treated with small molecule perturbagens

1. Release of Ku and MRN from DNA ends by Mre11 nuclease activity and Ctp1 is required for homologous r…
2. Identification of a DNA nonhomologous end-joining complex in bacteria.

There were no clinical trials for nonhomologous end joining complex